Have you been diagnosed with Hepatocellular Carcinoma (HCC), also referred to as Liver Cancer? If so, you may be a good fit for a clinical trial to evaluate how 3 drugs work in combination, and which dose is the best to treat your disease. The 3 drugs are casdozokitug (casdozo-key-tug), toripalimab (tor-i-pal-i- mab) and bevacizumab (bev-uh-siz-oo-mab).

Have you been diagnosed with advanced breast, lung, colorectal, or bladder cancer and does your doctor plan to send a sample of your tumor for genetic testing? If so, then you may be able to take part in a research study that looks at whether an expert review of your tumor genetic test results can help your doctor identify better treatment options or clinical trials that may be suitable for your cancer.

Have you been diagnosed with anaplastic thyroid cancer? If so, you might be able to take part in a study to look at the effectiveness of taking cemiplimab and XL092 before and after surgery for your cancer.

Have you been diagnosed with metastatic non-small cell lung cancer? If so, you may be able to take part in a research study looking to compare the safety and effectiveness of pembrolizumab to the investigational drug, ivonescimab in treating this condition.

Have you been diagnosed with metastatic cutaneous melanoma? Have you previously been treated for your melanoma, or maybe it can't be removed? If so, you might be eligible to take part in a study to compare how well a new drug, IMA203, can treat your cancer compared to your physician's choice of treatment.

Do you have Relapsed and Refractory CLL, SLL, or Select Low-grade Lymphomas? Have you received at least 2 or more therapies that have included BTKi and venetoclax? If so, you may be able to take part in a study on a drug called ZE50-0134 to treat patients with these conditions. We will also check if various doses of this medicine are safe for treatment.

Are you scheduled for a breast, kidney, or liver biopsy at UNC hospital? Have had a diagnostic ultrasound of your breast, kidney, or liver at UNC hospital? If so, you may be able to take part in a study on a new ultrasound method called contrast-enhanced super-resolution (CESR) imaging. We want to help doctors better understand a patient's risk of cancer. Compensation provided.

Have you been diagnosed with CLL or other forms of indolent lymphoma? If so this could be a good study for you to paticipate in. One of the primary goals of this study is To investigate the feasibility of the referral and engagement process in fatigue mitigation intervention for cancer-related fatigue among adults with CLL or other forms of indolent lymphoma.

Do you have multiple myeloma (MM)? Has your MM returned after responding to initial treatment (relapsed) or is not responding to treatment (refractory)? If so, you may be able to participate in this cell therapy research study to learn more about using modified immune cells as possible treatment.

Do you have metastatic colorectal cancer? Does your cancer lack certain mutations? If so, you might be eligible to take part in a trial to look at the effects of an investigational anticancer drug given with normal therapy.